Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy.

Stefania CrucittaGiuliana RestanteMarzia Del ReIlaria BertoliniEleonora BonaEleonora RofiLorenzo FontanelliGiulia GianfilippoStefano FogliIrene StasiMatteo GhilliAndrea FontanaRomano Danesi

Published in: Cancer chemotherapy and pharmacology (2019)

These findings suggest an association between the eNOS c.-813C>T polymorphism and the development of proteinuria in mBC patients receiving a bevacizumab-based chemotherapy.

Keyphrases

nitric oxide synthase
metastatic breast cancer
nitric oxide
locally advanced
metastatic colorectal cancer
endothelial cells
squamous cell carcinoma
radiation therapy
chemotherapy induced
rectal cancer